ferric chloride has been researched along with Venous Thrombosis in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.94) | 18.2507 |
| 2000's | 10 (29.41) | 29.6817 |
| 2010's | 20 (58.82) | 24.3611 |
| 2020's | 3 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, J; Hu, S; Hu, Z; Ji, X; Luo, Y; Xiao, L; Zhao, H; Zhao, T | 1 |
| Brill, A; Campos, J | 1 |
| Gui, S; Li, P; Lin, B; Tang, P; Wu, Z; Yang, W; Ye, Y; Zhan, Y | 1 |
| Ci, H; Ge, X; Song, W; Tian, G; Zhang, Y | 1 |
| Liu, X; Lu, D; Ma, T; Meng, Q; Shen, Z; Sun, J; Yang, J; Yang, Z; Zhang, J; Zhang, Z | 1 |
| Cooley, B; Diaz, JA; Grover, SP; Henke, PK; Lal, BK; Mackman, N; Palmer, OR; Saha, P; Smith, A; Wakefield, TW | 1 |
| Bode, C; Boeynaems, JM; Duerschmied, D; Guenther, F; Hein, L; Herr, N; Idzko, M; Mauler, M; Robaye, B; Roming, F; Von Zur Muhlen, C; Witsch, T | 1 |
| Aleman, MM; Byrnes, JR; Cooley, BC; Heisler, MJ; Machlus, KR; Walton, BL; Wang, JG; Wolberg, AS | 1 |
| Abdurahman, A; Abdusalam, E; Bégaud, B; Berké, B; Iskander, G; Moore, N; Umar, A; Zhou, W | 1 |
| Fay, WP; Fish, PM; Ji, Y; Lohman, AW; Strawn, TL; Szalai, AJ; Wu, J | 1 |
| Chong, CM; Chu, IK; Cui, G; Guo, L; Hoi, MP; Lee, SM; Li, G; Quan, Q; Shan, L; Sun, Y; Wang, Y; Yu, P; Zhang, Z; Zhao, Y | 1 |
| Kong, X; Sheng, L; Wang, T; Xia, L; Xie, H; Xie, Y; Yan, J; Zhou, H | 1 |
| Kao, CY; Kao, JT; Lin, CN; Lin, SW; Shi, GY; Tao, MH; Wu, HL; Yang, YL; Yu, IS | 1 |
| Elg, M; Johansson, K; Kjaer, M; Pehrsson, S | 1 |
| Cardenas, JC; Church, FC; Krishnamurthy, J; Owens, AP; Sharpless, NE; Whinna, HC | 1 |
| Aghourian, MN; Blostein, MD; Lemarié, CA | 1 |
| Diaz, JA; Henke, PK; Mackman, N; Myers, DD; Obi, AT; Wakefield, TW; Wrobleski, SK | 1 |
| Barbera, F; Bird, JE; Revelli, JP; Schumacher, WA; Seiffert, D; Smith, PL; Wang, X | 1 |
| Barbera, F; Bird, JE; Huang, C; Schumacher, WA; Smith, PL; Wang, X | 1 |
| Bhayana, B; Hara, T; Jaffer, FA; Kessinger, CW; Khatri, A; Lin, CP; McCarthy, JR; Tearney, GJ; Thompson, B; Weissleder, R | 1 |
| Fitzgerald, ME; Gartner, TK; Joglekar, MV; Ware, J; Xu, J | 1 |
| Crescente, M; Demers, M; Ho-Tin-Noé, B; Thomas, GM; Voorhees, JR; Wagner, DD; Wong, SL | 1 |
| Henke, PK; Jaffer, FA; Kessinger, CW; Kim, JW; Li, C; Lin, CP; McCarthy, JR; Ripplinger, CM; Weissleder, R | 1 |
| Dellas, C; Konstantinides, S; Loskutoff, DJ; Neels, JG; Schäfer, K | 1 |
| Bachmann, G; Gerriets, T; Heil, M; Kaps, M; Madlener, K; Röttger, C; Stolz, E; Walberer, M; Wessels, T | 1 |
| Budihna, MV; Cerne, M; Drevensek, G; Peternel, L; Stalc, A; Stegnar, M | 1 |
| Chen, CY; Cooley, BC; Schmeling, G; Schwab, JP; Szema, L | 1 |
| Hsu, MY; Ogletree, ML; Schumacher, WA; Smith, PL; Wang, X | 1 |
| Chen, CY; Cooley, BC; Schmeling, G | 1 |
| Hsu, MY; Monticello, TM; Schumacher, WA; Steinbacher, TE; Wang, X | 1 |
| Gailani, D; Hsu, MY; Ogletree, ML; Schumacher, WA; Seiffert, DA; Smith, PL; Wang, X | 1 |
| Bird, E; Hsu, MY; Schumacher, WA; Smith, PL; Tamasi, JA; Wang, X | 1 |
| Wang, X | 1 |
| Fukazawa, T; Goto, Y; Hayashi, H; Inoue, Y; Komatsu, Y | 1 |
2 review(s) available for ferric chloride and Venous Thrombosis
| Article | Year |
|---|---|
By word of mouse: using animal models in venous thrombosis research.
Topics: Animals; Chlorides; Constriction, Pathologic; Disease Models, Animal; Femoral Vein; Ferric Compounds; Ligation; Mice; Pulmonary Embolism; Vena Cava, Inferior; Venous Thrombosis | 2020 |
Critical review of mouse models of venous thrombosis.
Topics: Animals; Chlorides; Constriction; Disease Models, Animal; Electrolysis; Ferric Compounds; Ligation; Mice; Vena Cava, Inferior; Venous Thrombosis | 2012 |
32 other study(ies) available for ferric chloride and Venous Thrombosis
| Article | Year |
|---|---|
A novel severe cerebral venous thrombosis rat model based on semi-ligation combined with ferric chloride and thrombin.
Topics: Animals; Infarction; Intracranial Thrombosis; Male; Rats; Rats, Sprague-Dawley; Sinus Thrombosis, Intracranial; Thrombin; Venous Thrombosis | 2022 |
Aqueous extract of Whitmania pigra Whitman ameliorates ferric chloride-induced venous thrombosis in rats via antioxidation.
Topics: Animals; Antioxidants; Chlorides; Ferric Compounds; Leeches; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Thrombosis; Venous Thrombosis | 2021 |
Edoxaban improves venous thrombosis via increasing hydrogen sulfide and homocysteine in rat model.
Topics: Animals; Anticoagulants; Chlorides; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelial Cells; Ferric Compounds; Gene Expression Regulation; Homocysteine; Hydrogen Sulfide; Male; Matrix Metalloproteinase 9; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazoles; Venous Thrombosis | 2017 |
Endothelial progenitor cell-derived exosomes, loaded with miR-126, promoted deep vein thrombosis resolution and recanalization.
Topics: Animals; Base Sequence; Bone Marrow Cells; Cadherins; Cell Movement; Cellular Senescence; Chlorides; Disease Models, Animal; Electroporation; Endothelial Progenitor Cells; Epidermal Growth Factor; Exosomes; Ferric Compounds; Insulin-Like Growth Factor I; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Primary Cell Culture; Protocadherins; Ribonucleotides; Vena Cava, Inferior; Venous Thrombosis | 2018 |
Choosing a Mouse Model of Venous Thrombosis.
Topics: Algorithms; Animals; Chlorides; Disease Models, Animal; Electrolysis; Endothelial Cells; Endothelium, Vascular; Ferric Compounds; Free Radicals; Hemorheology; Ligation; Mice; Recurrence; Research Design; Veins; Venous Thrombosis; Venules | 2019 |
Contrast ultrasound for the quantification of deep vein thrombosis in living mice: effects of enoxaparin and P2Y12 receptor inhibition.
Topics: Adenosine; Animals; Anticoagulants; Chlorides; Contrast Media; Enoxaparin; Ferric Compounds; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbubbles; Microscopy; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Sulfur Hexafluoride; Thrombosis; Ticagrelor; Ultrasonography; Vena Cava, Inferior; Venous Thrombosis | 2013 |
Elevated prothrombin promotes venous, but not arterial, thrombosis in mice.
Topics: Animals; Blood Coagulation; Blood Platelets; Carotid Arteries; Chlorides; Disease Models, Animal; Femoral Vein; Ferric Compounds; Fibrin; Humans; Mice; Noxae; Prothrombin; Risk Factors; Thrombophilia; Vena Cava, Inferior; Venous Thrombosis | 2013 |
Effects of Cydonia oblonga Miller extracts on blood hemostasis, coagulation and fibrinolysis in mice, and experimental thrombosis in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Coagulation; Cardiovascular Agents; Carotid Artery Thrombosis; Chlorides; Collagen; Epinephrine; Ferric Compounds; Fibrinolysis; Hemostasis; Male; Mice, Inbred ICR; Phytotherapy; Plant Extracts; Plant Leaves; Pulmonary Embolism; Rats, Wistar; Rosaceae; Thromboxane B2; Vena Cava, Inferior; Venous Thrombosis | 2014 |
C-reactive protein induces expression of tissue factor and plasminogen activator inhibitor-1 and promotes fibrin accumulation in vein grafts.
Topics: Animals; C-Reactive Protein; Cell Movement; Chlorides; Coronary Artery Bypass; Ferric Compounds; Fibrin; Humans; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plasminogen Activator Inhibitor 1; Recombinant Proteins; Thromboplastin; Transgenes; Veins; Venous Thrombosis | 2014 |
Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Cell Adhesion Molecules; Chlorides; Disease Models, Animal; Enzyme Activation; Ferric Compounds; Fibrinolytic Agents; Gene Expression Regulation; Heme Oxygenase-1; Humans; Lactates; Microfilament Proteins; Models, Biological; P-Selectin; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Disulfide-Isomerases; Proteomics; Rats; Thrombosis; Venous Thrombosis | 2015 |
TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Carotid Artery Thrombosis; Cell Adhesion; Chlorides; Disease Models, Animal; E-Selectin; Femoral Vein; Ferric Compounds; Immunoglobulin G; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Mice; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Venous Thrombosis | 2015 |
FIX-Triple, a gain-of-function factor IX variant, improves haemostasis in mouse models without increased risk of thrombosis.
Topics: Animals; Chlorides; Coagulants; Dependovirus; Disease Models, Animal; Dose-Response Relationship, Drug; Factor IX; Ferric Compounds; Genetic Therapy; Genetic Vectors; Hemophilia B; Hemostasis; Humans; Infusions, Intravenous; Laser-Doppler Flowmetry; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Mutation; Recombinant Proteins; Risk Assessment; Thrombelastography; Time Factors; Venous Thrombosis | 2010 |
Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
Topics: Amidines; Animals; Antithrombin III; Antithrombins; Azetidines; Blood Coagulation; Chlorides; Dalteparin; Disease Models, Animal; Dose-Response Relationship, Drug; Ferric Compounds; Fibrinolytic Agents; Hemorrhage; Infusions, Intravenous; Male; Partial Thromboplastin Time; Peptide Hydrolases; Prodrugs; Rats; Rats, Sprague-Dawley; Thrombin; Thrombin Time; Thrombosis; Venous Thrombosis | 2010 |
Overexpression of the cell cycle inhibitor p16INK4a promotes a prothrombotic phenotype following vascular injury in mice.
Topics: Animals; Blood Coagulation; Blood Coagulation Tests; Bone Marrow Transplantation; Chlorides; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Ferric Compounds; Genotype; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Ligation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenotype; Plasminogen Activator Inhibitor 1; Rose Bengal; Time Factors; Up-Regulation; Vascular System Injuries; Venous Thrombosis | 2011 |
In vivo monitoring of venous thrombosis in mice.
Topics: Animals; Anticoagulants; Blood Coagulation; Chlorides; Dalteparin; Disease Models, Animal; Ferric Compounds; Ligation; Male; Mice; Mice, Inbred C57BL; Monitoring, Physiologic; Time Factors; Ultrasonography, Doppler, Color; Ultrasonography, Doppler, Pulsed; Vena Cava, Inferior; Venous Thrombosis | 2012 |
Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait.
Topics: Animals; Bleeding Time; Chlorides; Disease Models, Animal; Ferric Compounds; Hemorrhage; Hemostasis; Heterozygote; Mice; Mice, Knockout; Oligonucleotides, Antisense; Partial Thromboplastin Time; Phenotype; Plasma Kallikrein; Prekallikrein; Thrombosis; Time Factors; Venous Thrombosis | 2012 |
A platelet target for venous thrombosis? P2Y1 deletion or antagonism protects mice from vena cava thrombosis.
Topics: Animals; Blood Platelets; Chlorides; Deoxyadenine Nucleotides; Ferric Compounds; Gene Deletion; Mice; Mice, Knockout; Noxae; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2Y1; Venae Cavae; Venous Thrombosis | 2012 |
Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.
Topics: Animals; Chlorides; Disease Models, Animal; Femoral Vein; Ferric Compounds; Fibrin; Fluorescent Dyes; Half-Life; Humans; Indoles; Injections, Intravenous; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Microscopy, Fluorescence; Molecular Imaging; Oligopeptides; Phlebography; Radionuclide Imaging; Spectroscopy, Near-Infrared; Tissue Distribution; Tomography, X-Ray Computed; Venous Thrombosis | 2012 |
Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl(3)-induced occlusive thrombus formation in the inferior vena cava of mice.
Topics: Animals; Blood Platelets; Chlorides; Disease Models, Animal; Ferric Compounds; Mice; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Vena Cava, Inferior; Venous Thrombosis; von Willebrand Factor | 2013 |
ADAMTS13 exerts a thrombolytic effect in microcirculation.
Topics: ADAM Proteins; ADAMTS13 Protein; Animals; Chlorides; Computer Systems; Disease Models, Animal; Drug Evaluation, Preclinical; Ferric Compounds; Fibrinolytic Agents; Hemorrhage; Humans; Male; Mice; Mice, Inbred C57BL; Microcirculation; Microscopy; Recombinant Proteins; Skin Window Technique; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis; Venules | 2012 |
Inflammation modulates murine venous thrombosis resolution in vivo: assessment by multimodal fluorescence molecular imaging.
Topics: Animals; Biomarkers; Chlorides; Dextrans; Disease Models, Animal; Femoral Vein; Ferric Compounds; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Inflammation; Jugular Veins; Macrophages; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Microscopy, Fluorescence; Molecular Imaging; Phlebography; Prognosis; Reproducibility of Results; Saphenous Vein; Severity of Illness Index; Time Factors; Tomography, X-Ray Computed; Venous Thrombosis | 2012 |
Inhibition of endogenous leptin protects mice from arterial and venous thrombosis.
Topics: Animals; Antibodies, Blocking; Arterial Occlusive Diseases; Chlorides; Ferric Compounds; Leptin; Mice; Mice, Inbred C57BL; Receptors, Cell Surface; Receptors, Leptin; Venous Thrombosis | 2004 |
Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
Topics: Abciximab; Angiography; Animals; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Chlorides; Disease Models, Animal; Edema; Enoxaparin; Ferric Compounds; Heparin; Humans; Hydrogen-Ion Concentration; Immunoglobulin Fab Fragments; Intracranial Embolism and Thrombosis; Magnetic Resonance Imaging; Male; Rats; Recombinant Proteins; Sagittal Sinus Thrombosis; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis | 2005 |
Evaluation of two experimental venous thrombosis models in the rat.
Topics: Animals; Blood Coagulation Tests; Chlorides; Disease Models, Animal; Female; Ferric Compounds; Hemostasis; Male; Nadroparin; Rats; Rats, Wistar; Regression Analysis; Sensitivity and Specificity; Thromboplastin; Thrombosis; Venous Thrombosis | 2005 |
A murine model of deep vein thrombosis: characterization and validation in transgenic mice.
Topics: Animals; Anticoagulants; Chlorides; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Drug Evaluation, Preclinical; Electric Stimulation; Factor V; Femoral Vein; Ferric Compounds; Heparin; Mice; Mice, Inbred C57BL; Mice, Transgenic; Point Mutation; Reproducibility of Results; Venous Thrombosis | 2005 |
Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor.
Topics: Animals; Carboxypeptidase B2; Carboxypeptidases; Carotid Artery Thrombosis; Chlorides; Disease Models, Animal; Ferric Compounds; Fibrinolytic Agents; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Plant Proteins; Protease Inhibitors; Solanum tuberosum; Thrombolytic Therapy; Venae Cavae; Venous Thrombosis | 2006 |
Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
Topics: Amino Acid Substitution; Animals; Arginine; Arterial Occlusive Diseases; Arteries; Chlorides; Disease Models, Animal; Factor V; Ferric Compounds; Gene Frequency; Glutamine; Homozygote; Mice; Mice, Inbred C57BL; Mutation; Thrombosis; Venous Thrombosis | 2007 |
Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction.
Topics: Animals; Blood Platelets; Chemokine CCL2; Chlorides; Disease Models, Animal; Ferric Compounds; Gene Expression; Interleukin-1beta; Male; Microscopy, Electron; Nitric Oxide Synthase Type II; P-Selectin; Platelet Factor 4; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Saline Solution, Hypertonic; Thrombin; Thrombosis; Venae Cavae; Venous Thrombosis | 2007 |
Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice.
Topics: Animals; Chlorides; Disease Models, Animal; Factor XI Deficiency; Ferric Compounds; Fibrinolysis; Fibrinolytic Agents; Mice; Venae Cavae; Venous Thrombosis | 2006 |
Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis.
Topics: Animals; Bleeding Time; Carboxypeptidase B2; Carotid Artery Diseases; Chlorides; Coagulants; Disease Models, Animal; Female; Ferric Compounds; Male; Mice; Mice, Knockout; Plant Proteins; Protease Inhibitors; Thrombelastography; Venae Cavae; Venous Thrombosis | 2007 |
Lipopolysaccharide augments venous and arterial thrombosis in the mouse.
Topics: Animals; Arteries; Carotid Artery Thrombosis; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Ferric Compounds; Fibrinolytic Agents; Interleukin-1beta; Lipopolysaccharides; Mice; Mice, Inbred C57BL; RNA, Messenger; Thrombosis; Time Factors; Tumor Necrosis Factor-alpha; Veins; Venae Cavae; Venous Thrombosis | 2008 |
Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
Topics: Amino Acid Sequence; Animals; Arginine; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical; Chlorides; Drug Evaluation, Preclinical; Ferric Compounds; Fibrinolytic Agents; Glass; Hemorrhage; Heparin; Hirudin Therapy; Hirudins; Molecular Sequence Data; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Serine Proteinase Inhibitors; Sulfonamides; Thrombin; Thrombosis; Vena Cava, Inferior; Venous Thrombosis | 1999 |